1. European Medicines Agency, Amsterdam, The Netherlands.
2. BioNTech SE, Mainz, Germany.
3. Medicines Evaluation Board (MEB), Utrecht, The Netherlands.
4. DG Research and Innovation, European Commission, Brussels, Belgium.
5. Paul Ehrlich Institute (PEI), Langen, Germany.
6. Medical Products Agency (MPA), Uppsala, Sweden.
7. Ionis Pharmaceuticals, Inc., Carlsbad, California, USA.
8. RCSI University of Medicine and Health Sciences College of Surgeons RCSI and FutureNeuro SFI Research Centre, Dublin, Ireland.
9. University College London (UCL), NIHR Great Ormond Street Hospital Biomedical Research Centre, London, United Kingdom.
10. Silence Therapeutics GmbH, Berlin, Germany.
11. Central Committee on Research Involving Human Subjects (CCMO), The Hague, The Netherlands.
12. Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
13. VSOP - Patient Alliance for Rare and Genetic Diseases, Soest, The Netherlands.
14. Department of Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Germany.
15. Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
16. Agency of Medicines and Medical Products (AEMPS), Madrid, Spain.
17. ModernaCambridge, Massachusetts, USA.
18. OrbiMed, Boston, Massachusetts, USA.
19. Leiden University Medical Center, Leiden, The Netherlands.